Blood test could replace scans for HPV cancer patients
NCT ID NCT06640283
First seen Jan 04, 2026 · Last updated May 07, 2026 · Updated 20 times
Summary
This study is testing a new, low-cost blood test that looks for tumor DNA (ctDNA) in people with HPV-related cervical or anal cancer after they finish radiation therapy. The goal is to see if this simple blood test can replace expensive imaging scans for monitoring and help doctors decide who might benefit from early immunotherapy. About 150 participants will be followed over time to see if the test accurately predicts recurrence or spread of the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV-RELATED CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Instituto do Câncer do Estado de São Paulo - ICESP
RECRUITINGSão Paulo, 01246-000, Brazil
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.